Menu

Blog

Page 1229

Nov 1, 2023

Space Force awards $2.5 billion in rocket contracts to SpaceX and ULA for 21 launches

Posted by in categories: military, space

The U.S. Space Force assigned 21 rocket launches to SpaceX and United Launch Alliance, worth about $2.5 billion in total, the military branch told CNBC.

Space Force’s Space Systems Command on Tuesday announced the mission assignments, which represent the last round of orders under a multiyear program called National Security Space Launch (NSSL) Phase 2.

The final batch of assignments were split almost evenly, according to Col. Doug Pentecost, the deputy program executive officer of the Space Force’s Space Systems Command. ULA received 11 missions, valued at $1.3 billion, and SpaceX received 10 missions, valued at $1.23 billion.

Nov 1, 2023

At Abundance 360, David Sinclair made quite a number of encouraging comments about the future of aging research, including methods of resetting epigenetics to a youthful state

Posted by in categories: bioengineering, biotech/medical, chemistry, genetics, life extension, Peter Diamandis, robotics/AI

Emmett Short discusses these comments on this episode of Lifespan News.

But first, the mad scientist David Sinclair, this time with Peter Diamandis at Abundance 360, giving more details into human trials for the genetic engineering side of the technology versus the chemical and pill side of the technology. Which would you want more? We’ll also hear David’s thoughts on how AI will affect the advancement of this tech. Spoiler: A lot. I’m going to play the best parts and add my commentary along the way.

Nov 1, 2023

Indian start-up develops autonomous cotton picker

Posted by in categories: food, robotics/AI, sustainability

Indian start-up Green Robot Machinery (GRoboMac) has developed a cotton picker with autonomous robotic arms, mounted on a semi-autonomous electric farm vehicle.

The robotic arms of the battery-operated machine are each capable of picking about 50 kgs cotton per day. That means that four arms, mounted on the vehicle, can pick about 200 kgs per day. High yielding farms can use additional arms, the company says.

Nov 1, 2023

Personalized Deep Brain Stimulation Device May Quiet OCD Compulsions

Posted by in category: neuroscience

A novel type of deep brain stimulation known as responsive deep brain stimulation helped improve symptoms in a woman with severe OCD, according to a new study.

Nov 1, 2023

HbA1c: What’s Optimal, What’s My Data?

Posted by in categories: biotech/medical, genetics, life extension

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
Telomere and Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

Continue reading “HbA1c: What’s Optimal, What’s My Data?” »

Nov 1, 2023

Study finds pleasurable music and ‘chills’ predict music-induced hypoalgesia

Posted by in categories: biotech/medical, media & arts, neuroscience

Music for pain relief and anxiety. I think somewhere else I read it helps heal brain injuries.


Further, subject-preferred music appears to induce a superior effect in relieving pain. This can be approached by allowing participants to select the most pleasant music from a prespecified list of songs or listen to their favorite music during the study. Nevertheless, the richness of emotions, meanings, and associations involved when listening to favorite music is poorly understood, especially regarding pain relief.

About the study

Continue reading “Study finds pleasurable music and ‘chills’ predict music-induced hypoalgesia” »

Nov 1, 2023

Alternative funeral options are changing how we honor our dead

Posted by in categories: chemistry, sustainability

When someone dies in the US, the vast majority of the time, their body is either embalmed, placed in a coffin, and buried in a cemetery, or cremated and the ashes returned to their loved ones in an urn — but those aren’t the only options.

A growing number of funeral directors, startups, and nonprofits are providing people with alternative ways to have their bodies honored after death — suggesting that the funeral landscape of tomorrow won’t be so binary.

Traditional burial and cremation has a cost for the environment, releasing chemicals into the ground or greenhouse gasses into the air, but a number of other funeral options are showing that death can be green.

Nov 1, 2023

Heart failure no longer death sentence for cancer survivors

Posted by in category: biotech/medical

Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer.1The ground-breaking RESILIENCE project aims to prevent heart failure in patients who need anthracyclines to treat their cancer.

International experts and patients from the project gathered yesterday at the European Heart House, home of the European Society of Cardiology (ESC), as a unique think tank to improve the healthcare and quality of life for patients with cancer.

It is estimated that four million Europeans are diagnosed with cancer every year.2 Anthracycline chemotherapy has a prominent role in treating many forms of cancer-for example, up to 70% of patients with lymphoma receive an anthracycline regimen. Currently, there is no therapy to prevent anthracycline cardiotoxicity.

Nov 1, 2023

Brain implant lets man with locked-in syndrome share thoughts

Posted by in categories: computing, neuroscience

“To our knowledge, ours is the first study to achieve communication by someone who has no remaining voluntary movement.” — Jonas Zimmermann, a Wyss Center neuroscientist. Watch it here: https://www.freethink.com/health/locked-in-syndrome Freethink.


A man with total locked-in syndrome has used a brain-computer interface to spell out sentences with his mind.

Nov 1, 2023

New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

Posted by in categories: bioengineering, biotech/medical

The Wistar Institute’s David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells through a unique surface receptor that activates the immune system to fight against cancer.

In their publication titled, “Siglec-7 glyco-immune binding MAbs or NK cell engager biologics induce potent anti-tumor immunity against ,” published in Science Advances, the team demonstrates the preclinical feasibility of utilizing these new cancer immunotherapeutic approaches against diverse ovarian cancer types, including treatment-resistant and refractory ovarian cancers—alone or in combination with checkpoint inhibitor treatment.

The research started as a collaboration between Wistar’s Drs. Weiner and Mohamed Abdel-Mohsen, who were exploring the development of new glyco-signaling biologic tools that may be important in the fight against cancer.